Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
The New England Journal of Medicine
|
February 1, 2018
Therapy for Spinal Muscular Atrophy
Richard S Finkel, Wildon Farwell
Advances in Therapy
|
September 13, 2019
Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, et al. Adv Ther (2019) 36(5):1164-76. doi:10.1007/s12325-019-00923-8
Alfred W Sandrock, Wildon Farwell
Journal of the American Geriatrics Society
|
October 2, 2009
Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system
Rohini K Hernandez, Wildon Farwell, Michael D Cantor, et al.
Journal of Neuromuscular Diseases
|
February 22, 2021
14-Year Changes in Plasma Neurofilament Levels Among Men: A Pilot Study
Pamela M Rist, Varant Kupelian, Marco Petrillo, et al.
Orphanet Journal of Rare Diseases
|
November 30, 2017
Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States
Cathy Lally, Cynthia Jones, Wildon Farwell, et al.
Blood Cells, Molecules & Diseases
|
February 9, 2017
The targeted eosinophil-lowering effects of dexpramipexole in clinical studies
Steven I Dworetzky, Gregory T Hebrank, Donald G Archibald, et al.
Journal of Clinical Pharmacology
|
June 27, 2014
Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function
Ping He, Doug Kerr, Thomas Marbury, et al.
Journal of Neuromuscular Diseases
|
November 11, 2019
Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort
Cynthia C Jones, Suzanne F Cook, Jill Jarecki, et al.
CNS Drugs
|
August 18, 2019
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials
Basil T Darras, Michelle A Farrar, Eugenio Mercuri, et al.
Journal of Neuromuscular Diseases
|
June 6, 2018
Position Statement: Sharing of Clinical Research Data in Spinal Muscular Atrophy to Accelerate Research and Improve Outcomes for Patients
Hanns Lochmüller, David Evans, Wildon Farwell, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
The New England Journal of Medicine
|
February 1, 2018
Therapy for Spinal Muscular Atrophy
Richard S Finkel, Wildon Farwell
Advances in Therapy
|
September 13, 2019
Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, et al. Adv Ther (2019) 36(5):1164-76. doi:10.1007/s12325-019-00923-8
Alfred W Sandrock, Wildon Farwell
Journal of the American Geriatrics Society
|
October 2, 2009
Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system
Rohini K Hernandez, Wildon Farwell, Michael D Cantor, et al.
Journal of Neuromuscular Diseases
|
February 22, 2021
14-Year Changes in Plasma Neurofilament Levels Among Men: A Pilot Study
Pamela M Rist, Varant Kupelian, Marco Petrillo, et al.
Orphanet Journal of Rare Diseases
|
November 30, 2017
Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States
Cathy Lally, Cynthia Jones, Wildon Farwell, et al.
Blood Cells, Molecules & Diseases
|
February 9, 2017
The targeted eosinophil-lowering effects of dexpramipexole in clinical studies
Steven I Dworetzky, Gregory T Hebrank, Donald G Archibald, et al.
Journal of Clinical Pharmacology
|
June 27, 2014
Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function
Ping He, Doug Kerr, Thomas Marbury, et al.
Journal of Neuromuscular Diseases
|
November 11, 2019
Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort
Cynthia C Jones, Suzanne F Cook, Jill Jarecki, et al.
CNS Drugs
|
August 18, 2019
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials
Basil T Darras, Michelle A Farrar, Eugenio Mercuri, et al.
Journal of Neuromuscular Diseases
|
June 6, 2018
Position Statement: Sharing of Clinical Research Data in Spinal Muscular Atrophy to Accelerate Research and Improve Outcomes for Patients
Hanns Lochmüller, David Evans, Wildon Farwell, et al.
Page
of 3